Christophe Verbeeck

1.9k total citations
9 papers, 1.2k citations indexed

About

Christophe Verbeeck is a scholar working on Neurology, Physiology and Neurology. According to data from OpenAlex, Christophe Verbeeck has authored 9 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Neurology, 5 papers in Physiology and 3 papers in Neurology. Recurrent topics in Christophe Verbeeck's work include Alzheimer's disease research and treatments (5 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers) and Tryptophan and brain disorders (3 papers). Christophe Verbeeck is often cited by papers focused on Alzheimer's disease research and treatments (5 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers) and Tryptophan and brain disorders (3 papers). Christophe Verbeeck collaborates with scholars based in United States, Sweden and Poland. Christophe Verbeeck's co-authors include Pritam Das, Todd E. Golde, Carolina Ceballos‐Diaz, Paramita Chakrabarty, Dennis W. Dickson, Steven G. Younkin, Rosa Rademakers, Yona Levites, John Denis Fryer and Yuka Atagi and has published in prestigious journals such as Journal of Biological Chemistry, Neuron and Journal of Neuroscience.

In The Last Decade

Christophe Verbeeck

9 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christophe Verbeeck United States 9 753 633 321 267 215 9 1.2k
Cheryl E. G. Leyns United States 10 994 1.3× 847 1.3× 362 1.1× 356 1.3× 183 0.9× 13 1.5k
Lu-Lin Jiang United States 12 814 1.1× 584 0.9× 381 1.2× 319 1.2× 145 0.7× 13 1.3k
Elizabeth Allison United States 4 761 1.0× 750 1.2× 230 0.7× 281 1.1× 196 0.9× 4 1.2k
Nicola Fattorelli Belgium 8 841 1.1× 516 0.8× 369 1.1× 438 1.6× 151 0.7× 9 1.3k
Javier Remolina Serrano United States 10 876 1.2× 826 1.3× 283 0.9× 301 1.1× 150 0.7× 13 1.3k
Adrián Olmos‐Alonso United Kingdom 7 1.3k 1.7× 522 0.8× 632 2.0× 252 0.9× 219 1.0× 7 1.6k
Leen Wolfs United Kingdom 8 729 1.0× 435 0.7× 321 1.0× 373 1.4× 133 0.6× 12 1.1k
Lindsay A. Hohsfield United States 15 699 0.9× 315 0.5× 301 0.9× 229 0.9× 117 0.5× 23 1.1k
Jennifer Rodriguez-Rivera United States 8 455 0.6× 490 0.8× 133 0.4× 376 1.4× 102 0.5× 8 1.0k
Juan Ramón Perea Spain 13 542 0.7× 550 0.9× 136 0.4× 264 1.0× 111 0.5× 16 972

Countries citing papers authored by Christophe Verbeeck

Since Specialization
Citations

This map shows the geographic impact of Christophe Verbeeck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christophe Verbeeck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christophe Verbeeck more than expected).

Fields of papers citing papers by Christophe Verbeeck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christophe Verbeeck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christophe Verbeeck. The network helps show where Christophe Verbeeck may publish in the future.

Co-authorship network of co-authors of Christophe Verbeeck

This figure shows the co-authorship network connecting the top 25 collaborators of Christophe Verbeeck. A scholar is included among the top collaborators of Christophe Verbeeck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christophe Verbeeck. Christophe Verbeeck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Verbeeck, Christophe, Anna Carrano, Paramita Chakrabarty, Joanna L. Jankowsky, & Pritam Das. (2017). Combination of Aβ Suppression and Innate Immune Activation in the Brain Significantly Attenuates Amyloid Plaque Deposition. American Journal Of Pathology. 187(12). 2886–2894. 8 indexed citations
2.
Atagi, Yuka, Chia‐Chen Liu, Meghan M. Painter, et al.. (2015). Apolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2). Journal of Biological Chemistry. 290(43). 26043–26050. 397 indexed citations
3.
Chakrabarty, Paramita, Andrew Li, Carolina Ceballos‐Diaz, et al.. (2015). IL-10 Alters Immunoproteostasis in APP Mice, Increasing Plaque Burden and Worsening Cognitive Behavior. Neuron. 85(3). 519–533. 283 indexed citations
4.
Ross, Owen A., Alexandra I. Soto‐Ortolaza, Michael G. Heckman, et al.. (2013). NOTCH3 Variants and Risk of Ischemic Stroke. PLoS ONE. 8(9). e75035–e75035. 27 indexed citations
5.
Das, Pritam, Christophe Verbeeck, Lisa M. Minter, et al.. (2012). Transient pharmacologic lowering of Aβ production prior to deposition results in sustained reduction of amyloid plaque pathology. Molecular Neurodegeneration. 7(1). 39–39. 25 indexed citations
6.
Verbeeck, Christophe, Qiudong Deng, Mariely DeJesus‐Hernandez, et al.. (2012). Expression of Fused in sarcoma mutations in mice recapitulates the neuropathology of FUS proteinopathies and provides insight into disease pathogenesis. Molecular Neurodegeneration. 7(1). 53–53. 52 indexed citations
7.
Puschmann, Andreas, Christophe Verbeeck, Michael G. Heckman, et al.. (2011). Human leukocyte antigen variation and Parkinson’s disease. Parkinsonism & Related Disorders. 17(5). 376–378. 30 indexed citations
8.
Chakrabarty, Paramita, Karen Jansen‐West, Amanda Beccard, et al.. (2009). Massive gliosis induced by interleukin‐6 suppresses Aβ deposition in vivo: evidence against inflammation as a driving force for amyloid deposition. The FASEB Journal. 24(2). 548–559. 261 indexed citations
9.
Kim, Jungsu, Virginia M. Miller, Yona Levites, et al.. (2008). BRI2 (ITM2b) Inhibits A  Deposition In Vivo. Journal of Neuroscience. 28(23). 6030–6036. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cheryl E. G. Leyns Breakdown of academic impact, for papers by Lu-Lin Jiang Breakdown of academic impact, for papers by Elizabeth Allison Breakdown of academic impact, for papers by Nicola Fattorelli Breakdown of academic impact, for papers by Javier Remolina Serrano Breakdown of academic impact, for papers by Adrián Olmos‐Alonso Breakdown of academic impact, for papers by Leen Wolfs Breakdown of academic impact, for papers by Lindsay A. Hohsfield Breakdown of academic impact, for papers by Jennifer Rodriguez-Rivera Breakdown of academic impact, for papers by Juan Ramón Perea
Rankless by CCL
2026